NCT07659535 Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on the Prevention of Type 2 Diabetes
| NCT ID | NCT07659535 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Skane |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 40,000 participants |
| Start Date | 2026-06-15 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40,000 participants in total. It began in 2026-06-15 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall aim of the study is to investigate the incidence of type 2 diabetes in individuals who have access to a digital intervention tool as compared with randomized controls during three years. The tool is based on self-affirmation theory and has large emphasis on self-reflection to enable sustainable lifestyle changes. Users get access to expert-written information about relevant health topics and interact with an LLM to promote reflection on the information.
Eligibility Criteria
Inclusion criteria * Informed consent * Age above 35 years * Access to Internet and mobile or computer device Exclusion criteria * diabetes mellitus * conditions or treatments that in the judgement of the Investigator could affect the study evaluation * connection with the study team, funders, authorities, universities or other public or private bodies in such a way that specific interests in the study outcomes could be suspected. * living outside of Sweden * inability to read and write in Swedish
Contact & Investigator
Anders Rosengren, MD PhD
PRINCIPAL INVESTIGATOR
Göteborg University
Frequently Asked Questions
Who can join the NCT07659535 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07659535 currently recruiting?
Yes, NCT07659535 is actively recruiting participants. Contact the research team at birgitta.x.abrahamsson@skane.se for enrollment information.
Where is the NCT07659535 trial being conducted?
This trial is being conducted at Malmö, Sweden.
Who is sponsoring the NCT07659535 clinical trial?
NCT07659535 is sponsored by Region Skane. The principal investigator is Anders Rosengren, MD PhD at Göteborg University. The trial plans to enroll 40,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.